pyrroles has been researched along with Cachexia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Bora, V; Goyal, RK; Johar, K; Patel, BM; Patel, D | 1 |
Bani, MR; Bassi, A; Bisighini, C; Damia, G; Fiordaliso, F; Ghilardi, C; Giavazzi, R; Moschetta, M; Piccirillo, R; Pretto, F; Rovida, A; Scarlato, V; Talamini, L | 1 |
Giavazzi, R; Piccirillo, R | 1 |
Baracos, VE; Bathe, OF; Cervo, L; Giavazzi, R; Lecker, SH; Martinelli, GB; Olivari, D; Ottoboni, L; Piccirillo, R; Re Cecconi, AD; Resovi, A; Stretch, C; Talamini, L | 1 |
Audrain, O; Boucher, E; Leroux, C; Picot, D; Raoul, JL; Zoheir, Y | 1 |
5 other study(ies) available for pyrroles and Cachexia
Article | Year |
---|---|
Systemic study of selected histone deacetylase inhibitors in cardiac complications associated with cancer cachexia.
Topics: Animals; Benzamides; Butyric Acid; Cachexia; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Female; Heart Diseases; Histone Deacetylase Inhibitors; Hydroxamic Acids; Male; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasms; Pyridines; Pyrroles | 2022 |
Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle.
Topics: Angiogenesis Inhibitors; Animals; Cachexia; Carcinoma, Renal Cell; Cell Line, Tumor; Female; Humans; Indoles; Kidney Neoplasms; Male; Mice, Inbred C57BL; Mice, Nude; Muscle Proteins; Muscle, Skeletal; Protein Kinase Inhibitors; Pyrroles; Signal Transduction; STAT3 Transcription Factor; Sunitinib; Time Factors; Tripartite Motif Proteins; Tumor Burden; Ubiquitin-Protein Ligases; Weight Loss; X-Ray Microtomography; Xenograft Model Antitumor Assays | 2015 |
Inactivating STAT3: bad for tumor, good for muscle.
Topics: Angiogenesis Inhibitors; Animals; Cachexia; Carcinoma, Renal Cell; Female; Humans; Indoles; Kidney Neoplasms; Male; Muscle Proteins; Muscle, Skeletal; Protein Kinase Inhibitors; Pyrroles; STAT3 Transcription Factor; Ubiquitin-Protein Ligases | 2015 |
Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia.
Topics: Animals; Benzylamines; Biomarkers; Cachexia; Chemokine CXCL12; Cyclams; Cytokines; Disease Models, Animal; Female; Gene Expression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Indoles; Male; Mice; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscular Atrophy; Neoplasms; Pyrroles; Rats; Receptors, CXCR4; Signal Transduction; Sunitinib | 2016 |
Changes in resting energy expenditure (REE) as a function of tumor response to sunitinib in a cachexic patient with a metastatic endocrine tumor of the pancreas.
Topics: Antineoplastic Agents; Cachexia; Calorimetry, Indirect; Eating; Energy Metabolism; Hepatectomy; Humans; Indoles; Liver Neoplasms; Male; Middle Aged; Pancreatectomy; Pancreatic Neoplasms; Pyrroles; Rest; Splenectomy; Sunitinib; Treatment Outcome; Weight Loss | 2010 |